Intramuscular Olanzapine – a UK case series of early cases

BACKGROUND: Clinical trials assessing efficacy and safety of Intramuscular (IM) Olanzapine in acute schizophrenia and acute mania have previously been undertaken in studies required for drug registration in patients who were required to give informed consent. These patients may have less severe form...

Descripción completa

Detalles Bibliográficos
Autores principales: Bushe, Chris J, Taylor, Mark, Mathew, Mathew
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851705/
https://www.ncbi.nlm.nih.gov/pubmed/17397556
http://dx.doi.org/10.1186/1744-859X-6-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851705/
https://www.ncbi.nlm.nih.gov/pubmed/17397556
http://dx.doi.org/10.1186/1744-859X-6-11

Ejemplares similares